| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prognostic significance of T antigen expression in patients with gastric carcinoma.
|
Cancer
|
1996
|
1.43
|
|
2
|
Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis.
|
Int J Cancer
|
1997
|
1.32
|
|
3
|
Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis.
|
Clin Cancer Res
|
1998
|
1.07
|
|
4
|
Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.
|
Oncology
|
1998
|
1.05
|
|
5
|
Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma.
|
Int J Cancer
|
1997
|
1.02
|
|
6
|
Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.
|
Br J Cancer
|
1995
|
0.98
|
|
7
|
The detection of human pancreatic cancer-associated antigen in the serum of cancer patients.
|
Cancer
|
1987
|
0.98
|
|
8
|
Diagnostic usefulness of FDG PET for pancreatic mass lesions.
|
Ann Nucl Med
|
2001
|
0.97
|
|
9
|
A case of primary Hodgkin's disease of the stomach.
|
J Gastroenterol
|
1995
|
0.96
|
|
10
|
Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma.
|
Int J Cancer
|
1997
|
0.93
|
|
11
|
TGF-beta1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion.
|
Int J Oncol
|
2001
|
0.90
|
|
12
|
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
|
Cancer
|
1997
|
0.90
|
|
13
|
Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma.
|
Oncology
|
1998
|
0.90
|
|
14
|
Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma.
|
Oncol Rep
|
2011
|
0.90
|
|
15
|
Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival.
|
Int J Pancreatol
|
1995
|
0.86
|
|
16
|
A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis.
|
Int J Mol Med
|
2001
|
0.83
|
|
17
|
Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
|
Clin Cancer Res
|
2000
|
0.81
|
|
18
|
Diagnostic potential and pitfalls of ultrasound-guided fine-needle aspiration cytology for breast lesions.
|
Surg Today
|
1998
|
0.80
|
|
19
|
[Correlation between expression of RB protein and prognosis of gastric cancer].
|
Gan To Kagaku Ryoho
|
1996
|
0.80
|
|
20
|
TGF-beta1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination.
|
Int J Oncol
|
1998
|
0.80
|
|
21
|
[p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma].
|
Gan To Kagaku Ryoho
|
1998
|
0.78
|
|
22
|
[Establishment and characterization of a human breast cancer cell line, OCUB-1].
|
Hum Cell
|
1994
|
0.78
|
|
23
|
Intratumoral injection of an adriamycin immunoconjugate against human pancreatic cancer xenografts.
|
Jpn J Cancer Res
|
1995
|
0.78
|
|
24
|
Expression of the mismatch repair gene hMSH2 in sporadic colorectal cancer.
|
Int J Oncol
|
1998
|
0.78
|
|
25
|
The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.
|
Int J Pancreatol
|
1988
|
0.77
|
|
26
|
[Genome analyses for precancerous lesions in the gastrointestinal tract].
|
Gan To Kagaku Ryoho
|
2000
|
0.77
|
|
27
|
Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastric cancer cells with or without p53 mutation.
|
Int J Oncol
|
2001
|
0.77
|
|
28
|
Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP.
|
Cancer Chemother Pharmacol
|
1997
|
0.77
|
|
29
|
Caspase-1 activity as a possible predictor of apoptosis induced by cisplatin in gastric cancer cells.
|
Int J Mol Med
|
2000
|
0.76
|
|
30
|
Combined evaluation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression in gastric carcinoma.
|
Int J Oncol
|
1996
|
0.76
|
|
31
|
A clinical evaluation of various tumor markers for the diagnosis of pancreatic cancer.
|
Int J Pancreatol
|
1991
|
0.76
|
|
32
|
New radioimmunoassay for pancreatic cancer-associated antigen span-1 with reference to differential-diagnosis and monitoring in pancreatic-cancer.
|
Int J Oncol
|
1993
|
0.75
|
|
33
|
Prediction of disease relapse in patients with breast cancer.
|
Int J Oncol
|
1996
|
0.75
|
|
34
|
[Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
|
Gan To Kagaku Ryoho
|
1994
|
0.75
|
|
35
|
Overexpression of p53 associated with tumor angiogenesis, tumor cell proliferation, and prognosis in gastric carcinoma.
|
Oncol Rep
|
2011
|
0.75
|
|
36
|
A new cancer-associated antigen defined by a monoclonal antibody against a synthetic carbohydrate chain.
|
Int J Cancer
|
1994
|
0.75
|
|
37
|
Human monoclonal antibody prepared from lymphocytes of pancreatic cancer patients.
|
Pancreas
|
1989
|
0.75
|
|
38
|
Radioimmunodetection with 111In-labeled monoclonal antibody Nd2 in patients with pancreatic cancer.
|
Jpn J Cancer Res
|
1997
|
0.75
|
|
39
|
Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
|
J Exp Clin Cancer Res
|
2006
|
0.75
|
|
40
|
[Establishment of a new scirrhous gastric cancer cell line OCUM-2M from a primary gastric tumor].
|
Nihon Shokakibyo Gakkai Zasshi
|
1995
|
0.75
|
|
41
|
[Molecular size heterogeneity of SPan-1 antigen and co-expression with Lewis phenotype determinants in sera from gastrointestinal malignant diseases].
|
Nihon Shokakibyo Gakkai Zasshi
|
1992
|
0.75
|
|
42
|
[Malignancy of colorectal cancer analyzed by expression of cyclin D1].
|
Gan To Kagaku Ryoho
|
1997
|
0.75
|
|
43
|
Comparison between a newly established pancreatic cystadenocarcinoma cell-line, ocup-1 and cells derived from pancreatic ductal carcinoma.
|
Int J Oncol
|
1994
|
0.75
|
|
44
|
[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
|
Gan To Kagaku Ryoho
|
2000
|
0.75
|
|
45
|
[Basic and clinical evaluation of measurement of pancreatic cancer associated antigen, SPan-1].
|
Nihon Geka Gakkai Zasshi
|
1990
|
0.75
|
|
46
|
The thoracoscopic approach for internal mammary nodes in breast cancer.
|
Surg Endosc
|
2000
|
0.75
|
|
47
|
[Clinical application of pancreatic cancer associated antigen (Span-1 antigen)].
|
Nihon Shokakibyo Gakkai Zasshi
|
1988
|
0.75
|
|
48
|
[Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
|
Gan To Kagaku Ryoho
|
1995
|
0.75
|
|
49
|
[Combination therapy of 5-FU and low dose CDDP for advanced and recurrence gastric cancer].
|
Gan To Kagaku Ryoho
|
1995
|
0.75
|
|
50
|
[Immunohistochemical study of p21 expression in gastric carcinoma].
|
Gan To Kagaku Ryoho
|
1997
|
0.75
|
|
51
|
Various tumor markers for small pancreatic cancer with special reference to the present status of pancreatic cancer in Japan and our experience over the past 2 years.
|
Pancreas
|
1991
|
0.75
|